SEM
Select Medical Holdings Corporation15.27
-0.37-2.37%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Unpacks Q4 misses, outpatient fixes
Q&A drilled into Q4's EBITDA shortfall, quantifying $15M surprise health costs company-wide and $6M outpatient receivable write-offs, alongside payer mix erosion and staffing softness in select markets—deemed largely one-offs. Inpatient rehab shone same-store at 23%+ margins, startup losses mere timing blips totaling ~$15M for 2026. Outpatient rebound eyed via 2% Medicare boost, critical illness cautiously flat. Buybacks paused amid takeover review; minor weather and CMS demo risks flagged. Management non-committal on M&A process. Q&A reaffirmed inpatient strength. Watch outpatient traction.
Key Stats
Market Cap
1.89BP/E (TTM)
18.62Basic EPS (TTM)
0.82Dividend Yield
0.02%Recent Filings
8-K
Merger at $16.50/share announced
Select Medical signed a merger deal on March 2, 2026, with a consortium led by insiders Ortenzio and Jackson plus WCAS, paying $16.50 per share in cash—enterprise value $3.9 billion. Special committee blessed it as fair; needs majority non-affiliate stockholder nod and HSR clearance, eyeing mid-2026 close. Deal's fully financed. Risks loom if approvals fail.
8-K
Q4 results, dividend, buyout bid
Select Medical reported Q4 revenue up 6.4% to $1.4B and full-year revenue up 5.1% to $5.5B, with continuing ops income surging 65% to $214.5M; rehab hospitals drove growth at 15.2% quarterly revenue rise, yet outpatient EBITDA plunged 58%. Board declared $0.0625/share dividend payable March 12. Special Committee reviews Executive Chairman's $16-$16.20/share take-private bid.
10-K
FY2025 results
Select Medical Holdings posted FY2025 revenue of $5.5B, up 5% y/y, with critical illness recovery hospitals at $2.5B (45% of total) steady on flat admissions but 2% higher revenue per patient day to $2,230; rehab hospitals surged 16% to $1.3B on 8% more patient days despite 82% occupancy dip; outpatient clinics grew 3% to $1.3B via 3% visit gains, yet margins squeezed to 7%. Q4 momentum shone in rehab with accelerating admissions, but CIRH and outpatient lagged on cost pressures. Cash from operations funded $229M capex and $100M buybacks; revolver holds $469M availability. No annual guidance disclosed. Labor shortages risk quarterly momentum.
8-K
CEO Mullin employment deal
Select Medical locked in CEO Thomas P. Mullin with a new employment agreement dated December 17, 2025, effective January 1, 2026. It sets a $700,000 base salary, 12 months' severance for non-cause termination, and two-year non-compete plus non-solicit restrictions. Leadership continuity secured. Yet change-of-control falls to a prior letter.
8-K
Take-private bid at $16-$16.20/share
IPO
Employees
Sector
Industry
CYH
Community Health Systems, Inc.
3.25+0.03
EHC
Encompass Health Corporation
108.01+0.42
FCHS
First Choice Healthcare Solutio
0.01+0.00
FMS
Fresenius Medical Care AG
23.77+0.13
GBCS
Selectis Health,Inc.
1.95+0.00
HCA
HCA Healthcare, Inc.
469.79-7.19
NHC
National HealthCare Corporation
138.93-0.94
NUTX
Nutex Health Inc.
171.72-4.06
THC
Tenet Healthcare Corporation
196.88-0.44
USPH
U.S. Physical Therapy, Inc.
78.50-2.65